|
TTD
Drug ID:
DCL000805
Drug
Information |
Name | Flibanserin | Synonyms | 1-(2-(4-alpha,alpha,alpha-Trifluoro-m-tolyl)-1-piperazinyl)ethyl)-2-benzimidazolinone; PDSP1_001329; 3-[2-[4-[4-(trifluoromethyl)phenyl]piperazin-1-yl]ethyl]-1H-benzimidazol-2-one; UNII-37JK4STR6Z; 1,3-Dihydro-1-(2-(4-(3-(trifluoromethyl)phenyl)-1-piperazinyl)ethyl)-2H-benzimidazol-2-one; 1-(2-(4-(alpha,alpha,alpha-Trifluoro-m-tolyl)-1-piperazinyl)ethyl)-2-benzimidazolinone; MolPort-006-666-415; CID127941; Flibanserin [USAN]; Bimt-17; ST51054021; AC1L2SWZ; C20H21F3N4O; PDSP2_001313; 1-(2-(4-(3-Trifluoromethylphenyl)piperazin-1-yl)ethyl)benzimidazol(1H)-2-one; AC-1628; Flibanserin; LS-173616; Bimt 17 | Company | Boehringer Ingelheim | Indication | Female sexual dysfunction | Phase III [1] | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format | CAS Number | CAS 167933-07-5 | Formular | C20H21F3N4O | PubChem Compound ID | CID 127941. | PubChem Substance ID | SID 704574. | ClinicalTrials.gov | NCT00360529; | Target | 5-hydroxytryptamine receptor 1A |  | Agonist | [1] | 5-hydroxytryptamine receptor 1A |  | Multitarget | [1] | 5-hydroxytryptamine receptor 2A |  | Agonist | [1] | 5-hydroxytryptamine receptor 2A |  | Multitarget | [1] | Ref 1 | Designing drugs for the treatment of female sexual dysfunction. Drug Discov Today. 2007 Sep;12(17-18):757-66. Epub 2007 Aug 27. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|
|